Interferon-β Signaling Contributes to Ras Transformation
Author(s) -
YuChen Tsai,
Sidney Pestka,
Lu-Hai Wang,
Loren W. Runnels,
Shan Wan,
Yi Lisa Lyu,
Leroy F. Liu
Publication year - 2011
Publication title -
plos one
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.99
H-Index - 332
ISSN - 1932-6203
DOI - 10.1371/journal.pone.0024291
Subject(s) - oncogene , interferon , carcinogenesis , signal transduction , biology , malignant transformation , cancer research , interferon type i , microbiology and biotechnology , transformation (genetics) , cytokine , proto oncogene tyrosine protein kinase src , immunology , cell , cell cycle , cancer , genetics , gene
Increasing evidence has pointed to activated type I interferon signaling in tumors. However, the molecular basis for such activation and its role in tumorigenesis remain unclear. In the current studies, we report that activation of type I interferon (IFN) signaling in tumor cells is primarily due to elevated secretion of the type I interferon, IFN-β. Studies in oncogene-transformed cells suggest that oncogenes such as Ras and Src can activate IFN-β signaling. Significantly, elevated IFN-β signaling in Ras-transformed mammary epithelial MCF-10A cells was shown to contribute to Ras transformation as evidenced by morphological changes, anchorage-independent growth, and migratory properties. Our results demonstrate for the first time that the type I IFN, IFN-β, contributes to Ras transformation and support the notion that oncogene-induced cytokines play important roles in oncogene transformation.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom